Cargando…
Sublingual immunotherapy in allergic asthma: Current evidence and needs to meet
Allergen-specific immunotherapy is aimed at modifying the natural history of allergy by inducing tolerance to the causative allergen. In its traditional, subcutaneous form, immunotherapy has complete evidence of efficacy in allergic asthma. However, subcutaneous immunotherapy (SCIT) has a major flaw...
Autores principales: | Incorvaia, Cristoforo, Riario-Sforza, Gian Galeazzo, Incorvaia, Stefano, Frati, Franco |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2930649/ https://www.ncbi.nlm.nih.gov/pubmed/20835305 http://dx.doi.org/10.4103/1817-1737.65038 |
Ejemplares similares
-
IgE Depletion in Severe Asthma: What We Have and What Could Be Added in the Near Future
por: Incorvaia, Cristoforo, et al.
Publicado: (2017) -
Sublingual immunotherapy in children: facts and needs
por: Marseglia, Gian Luigi, et al.
Publicado: (2009) -
The current role of sublingual immunotherapy in the treatment of allergic rhinitis in adults and children
por: Incorvaia, Cristoforo, et al.
Publicado: (2011) -
Current and future applications of the anti-IgE antibody omalizumab
por: Incorvaia, Cristoforo, et al.
Publicado: (2008) -
Impairment of small airways in COPD patients with frequent exacerbations and effects of treatment with tiotropium
por: Incorvaia, Cristoforo, et al.
Publicado: (2008)